Evaluation of Differences in Metabolic and Immunologic Markers and Cardiovascular Risk in hiv-1 Patient

ABSTRACT: Introduction: hiv infection induces an exacerbated chronic inflammatory response, which triggers met abolic disorders and cardiovascular diseases; however, there are individuals, known as hiv controllers, who do not have typical progression markers. As cardiovascular risk tests are not acc...

Full description

Autores:
Castro Torres, Gustavo Andrés
León Quiroz, Kevin
Marín Palma, Leidy Damariz
Oyuela Gómez, Sarita María
Cataño Bedoya, Jhon Ubeimar
Duque Botero, Julieta
Giraldo Méndez, Diana Patricia
Taborda Vanegas, Natalia Andrea
Hernández López, Juan Carlos
Rugeles López, María Teresa
Jaimes, Francisco Alberto
Tipo de recurso:
Article of investigation
Fecha de publicación:
2021
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/36373
Acceso en línea:
https://hdl.handle.net/10495/36373
Palabra clave:
VIH-1
HIV-1
Enfermedades Cardiovasculares
Cardiovascular Diseases
Inflamación
Inflammation
Progresión de la Enfermedad
Disease Progression
Rights
openAccess
License
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
id UDEA2_878297133af81b855e224cb98b3d0ee7
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/36373
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv Evaluation of Differences in Metabolic and Immunologic Markers and Cardiovascular Risk in hiv-1 Patient
dc.title.translated.spa.fl_str_mv Avaliação da relação entre marcadores metabólicos, imunológicos e de risco cardiovascular em pacientes com hiv-1
Evaluación de la relación entre marcadores metabólicos, inmunológicos y de riesgo cardiovascular en pacientes con vih-1
title Evaluation of Differences in Metabolic and Immunologic Markers and Cardiovascular Risk in hiv-1 Patient
spellingShingle Evaluation of Differences in Metabolic and Immunologic Markers and Cardiovascular Risk in hiv-1 Patient
VIH-1
HIV-1
Enfermedades Cardiovasculares
Cardiovascular Diseases
Inflamación
Inflammation
Progresión de la Enfermedad
Disease Progression
title_short Evaluation of Differences in Metabolic and Immunologic Markers and Cardiovascular Risk in hiv-1 Patient
title_full Evaluation of Differences in Metabolic and Immunologic Markers and Cardiovascular Risk in hiv-1 Patient
title_fullStr Evaluation of Differences in Metabolic and Immunologic Markers and Cardiovascular Risk in hiv-1 Patient
title_full_unstemmed Evaluation of Differences in Metabolic and Immunologic Markers and Cardiovascular Risk in hiv-1 Patient
title_sort Evaluation of Differences in Metabolic and Immunologic Markers and Cardiovascular Risk in hiv-1 Patient
dc.creator.fl_str_mv Castro Torres, Gustavo Andrés
León Quiroz, Kevin
Marín Palma, Leidy Damariz
Oyuela Gómez, Sarita María
Cataño Bedoya, Jhon Ubeimar
Duque Botero, Julieta
Giraldo Méndez, Diana Patricia
Taborda Vanegas, Natalia Andrea
Hernández López, Juan Carlos
Rugeles López, María Teresa
Jaimes, Francisco Alberto
dc.contributor.author.none.fl_str_mv Castro Torres, Gustavo Andrés
León Quiroz, Kevin
Marín Palma, Leidy Damariz
Oyuela Gómez, Sarita María
Cataño Bedoya, Jhon Ubeimar
Duque Botero, Julieta
Giraldo Méndez, Diana Patricia
Taborda Vanegas, Natalia Andrea
Hernández López, Juan Carlos
Rugeles López, María Teresa
Jaimes, Francisco Alberto
dc.contributor.researchgroup.spa.fl_str_mv Inmunovirología
dc.subject.decs.none.fl_str_mv VIH-1
HIV-1
Enfermedades Cardiovasculares
Cardiovascular Diseases
Inflamación
Inflammation
Progresión de la Enfermedad
Disease Progression
topic VIH-1
HIV-1
Enfermedades Cardiovasculares
Cardiovascular Diseases
Inflamación
Inflammation
Progresión de la Enfermedad
Disease Progression
description ABSTRACT: Introduction: hiv infection induces an exacerbated chronic inflammatory response, which triggers met abolic disorders and cardiovascular diseases; however, there are individuals, known as hiv controllers, who do not have typical progression markers. As cardiovascular risk tests are not accurate on hiv-1 infected patients, the study of metabolic and inflammatory parameters in individuals with different patterns of progression could contribute to the definition of predictors of cardiovascular disease in this population. The aim of this study was to compare hiv controllers and hiv progressors (with and without antiretroviral therapy) as well as with healthy controls in order to explore differences and correlations in metabolic and inflammatory biomarkers associated with cardiovascular risk. Materials and methods: This was a cross-sectional analytical study which included 63 individuals infected with hiv-1 classified as hiv controllers or progressors (with or without antiretroviral therapy), and a healthy control group. The following parameters were determined: carotid intima-media thickness (cimt); cardiovascular risk scores; lipid profile, fasting glucose, high-sensitivity crp, D-dimer, sCD14, sCD163, il-6, and il-18. Data were compared with Anova or Kruskal–Wallis, and correlations were evaluated by the Spearman coef ficient. Results: While there were no significant differences in Framingham, dad or cimt values, hiv con trollers exhibited lower triglycerides levels when compared with hiv progressors. No differences were observed in markers, such as high-sensitivity crp, il-6, il-18, and sCD163, among the groups. The median hdl value was higher in hiv progressors on antiretroviral therapy, and cimt in hiv controllers was nega tively correlated with sCD14. Conclusion: hiv controllers have a different cardiovascular profile than hiv progressors according to their values in metabolic and immunological biomarker.
publishDate 2021
dc.date.issued.none.fl_str_mv 2021
dc.date.accessioned.none.fl_str_mv 2023-08-25T20:30:56Z
dc.date.available.none.fl_str_mv 2023-08-25T20:30:56Z
dc.type.spa.fl_str_mv Artículo de investigación
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ART
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.citation.spa.fl_str_mv Castro G, León K, Marín-Palma D, Oyuela SM, Cataño-Bedoya J-U, Duque-Botero J, Giraldo-Méndez DP, Taborda NA, Hernández JC, Rugeles MT, Jaimes FA. Evaluation of Differences in Metabolic and Immunologic Markers and Cardiovascular Risk in HIV-1 Patients Rev Cienc Salud. 2021;19(3):1-18.
dc.identifier.issn.none.fl_str_mv 1692-7273
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/10495/36373
dc.identifier.doi.none.fl_str_mv 10.12804/revistas.urosario.edu.co/revsalud/a.10532
dc.identifier.eissn.none.fl_str_mv 2145-4507
identifier_str_mv Castro G, León K, Marín-Palma D, Oyuela SM, Cataño-Bedoya J-U, Duque-Botero J, Giraldo-Méndez DP, Taborda NA, Hernández JC, Rugeles MT, Jaimes FA. Evaluation of Differences in Metabolic and Immunologic Markers and Cardiovascular Risk in HIV-1 Patients Rev Cienc Salud. 2021;19(3):1-18.
1692-7273
10.12804/revistas.urosario.edu.co/revsalud/a.10532
2145-4507
url https://hdl.handle.net/10495/36373
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournalabbrev.spa.fl_str_mv Rev. Cienc. Salud
dc.relation.citationendpage.spa.fl_str_mv 18
dc.relation.citationissue.spa.fl_str_mv 3
dc.relation.citationstartpage.spa.fl_str_mv 1
dc.relation.citationvolume.spa.fl_str_mv 19
dc.relation.ispartofjournal.spa.fl_str_mv Revista Ciencias de la Salud
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
https://creativecommons.org/licenses/by-nc-nd/4.0/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.extent.spa.fl_str_mv 18
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Universidad del Rosario, Escuela de Medicina y Ciencias de la Salud
dc.publisher.place.spa.fl_str_mv Bogotá, Colombia
institution Universidad de Antioquia
bitstream.url.fl_str_mv https://bibliotecadigital.udea.edu.co/bitstreams/33f6b4ee-1df8-486f-852c-e5dc5dfaa111/download
https://bibliotecadigital.udea.edu.co/bitstreams/87ca7470-369c-4b71-a14e-38d8c1c47683/download
https://bibliotecadigital.udea.edu.co/bitstreams/4c1bd81b-9958-4a32-9f34-d04045a4f148/download
https://bibliotecadigital.udea.edu.co/bitstreams/b179c938-7bd4-4674-9163-0fe17aa2fae4/download
https://bibliotecadigital.udea.edu.co/bitstreams/b7a9a250-e2f8-4b8e-a5da-2a83841743bd/download
bitstream.checksum.fl_str_mv b88b088d9957e670ce3b3fbe2eedbc13
8a4605be74aa9ea9d79846c1fba20a33
0af4898dfceb641ef57e749dc6283727
0df81b111855b981a2a41418c226f03b
f6de93ade7e3ed21999a7f9530e067fd
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional de la Universidad de Antioquia
repository.mail.fl_str_mv aplicacionbibliotecadigitalbiblioteca@udea.edu.co
_version_ 1851052400344825856
spelling Castro Torres, Gustavo AndrésLeón Quiroz, KevinMarín Palma, Leidy DamarizOyuela Gómez, Sarita MaríaCataño Bedoya, Jhon UbeimarDuque Botero, JulietaGiraldo Méndez, Diana PatriciaTaborda Vanegas, Natalia AndreaHernández López, Juan CarlosRugeles López, María TeresaJaimes, Francisco AlbertoInmunovirología2023-08-25T20:30:56Z2023-08-25T20:30:56Z2021Castro G, León K, Marín-Palma D, Oyuela SM, Cataño-Bedoya J-U, Duque-Botero J, Giraldo-Méndez DP, Taborda NA, Hernández JC, Rugeles MT, Jaimes FA. Evaluation of Differences in Metabolic and Immunologic Markers and Cardiovascular Risk in HIV-1 Patients Rev Cienc Salud. 2021;19(3):1-18.1692-7273https://hdl.handle.net/10495/3637310.12804/revistas.urosario.edu.co/revsalud/a.105322145-4507ABSTRACT: Introduction: hiv infection induces an exacerbated chronic inflammatory response, which triggers met abolic disorders and cardiovascular diseases; however, there are individuals, known as hiv controllers, who do not have typical progression markers. As cardiovascular risk tests are not accurate on hiv-1 infected patients, the study of metabolic and inflammatory parameters in individuals with different patterns of progression could contribute to the definition of predictors of cardiovascular disease in this population. The aim of this study was to compare hiv controllers and hiv progressors (with and without antiretroviral therapy) as well as with healthy controls in order to explore differences and correlations in metabolic and inflammatory biomarkers associated with cardiovascular risk. Materials and methods: This was a cross-sectional analytical study which included 63 individuals infected with hiv-1 classified as hiv controllers or progressors (with or without antiretroviral therapy), and a healthy control group. The following parameters were determined: carotid intima-media thickness (cimt); cardiovascular risk scores; lipid profile, fasting glucose, high-sensitivity crp, D-dimer, sCD14, sCD163, il-6, and il-18. Data were compared with Anova or Kruskal–Wallis, and correlations were evaluated by the Spearman coef ficient. Results: While there were no significant differences in Framingham, dad or cimt values, hiv con trollers exhibited lower triglycerides levels when compared with hiv progressors. No differences were observed in markers, such as high-sensitivity crp, il-6, il-18, and sCD163, among the groups. The median hdl value was higher in hiv progressors on antiretroviral therapy, and cimt in hiv controllers was nega tively correlated with sCD14. Conclusion: hiv controllers have a different cardiovascular profile than hiv progressors according to their values in metabolic and immunological biomarker.RESUMEN: Introducción: la infección por vih-1 induce una respuesta inflamatoria crónica exacerbada que desenca dena alteraciones metabólicas y cardiovasculares; sin embargo, algunos individuos “controladores” no presentan los marcadores de progresión típicos. Dado que las pruebas que evaluan el riesgo cardiovas cular carecen de precisión en pacientes con vih-1, el estudio de parámetros inflamatorios en individuos con diferente progresión podría aportar a la definición de predictores de enfermedad cardiovascular en esta población. El objetivo es explorar diferencias y correlaciones en biomarcadores metabólicos e infla matorios asociados con riesgo cardiovascular, comparando individuos controladores y progresores con y sin terapia antiviral. Materiales y métodos: estudio analítico transversal con 63 individuos infectados por vih-1, clasificados en controladores y progresores (con terapia antiviral y sin esta), y controles sanos. Se midió el grosor de la íntima media carotidea (cimt), puntajes de riesgo cardiovascular y cuantificación de perfil lipídico, glucemia en ayunas, pcr ultrasensible, dímero D, sCD14, sCD163, il-6 e il-18. Se realizó comparación por Anova o KruskalWallis y correlación por coeficiente de Spearman. Resultados: no hubo diferencias significativas en índices deFramingham, dad o cimt, pero los individuos controladores presen taron menores valores de triglicéridos, comparados con los progresores. No se observaron diferencias en pcr ultrasensible, il-6, il-18, y sCD163, entre los grupos estudiados. La mediana del hdl fue mayor en los progresores con terapia antiviral y el cimt en los controladores se correlacionó negativamente con sCD14. Conclusión: los individuos controladores presentan un perfil cardiovascular diferente a los individuos progresores, de acuerdo con los biomarcadores metabólicos e inmunológicos evaluadosRESUMO: Introdução: a infecção pelo hiv-1 induz resposta inflamatória crônica exacerbada, que desencadeia alte rações metabólicas e doenças cardiovasculares; no entanto, existem indivíduos, chamados controlado res, que não possuem os marcadores de progressão típicos. Tendo em vista que os testes que avaliam o risco cardiovascular carecem de precisão em pacientes com hiv-1, o estudo de parâmetros metabólicos e inflamatórios em indivíduos com diferentes padrões de progressão pode contribuir para a definição de preditores de doença cardiovascular nessa população. O objetivo é explorar diferenças e correlações em biomarcadores metabólicos e inflamatórios associados ao risco cardiovascular, comparando indiví duos controladores e progressores submetidos ou não à terapia antiviral. Materiais e métodos: Estudo analítico transversal que incluiu 63 indivíduos infectados pelo hiv-1, classificados como controladores e progressores (com e sem terapia antiviral), além de grupos controle saudáveis. Realizou-se a medição da espessura da íntima média da carótida (cimt), pontuações de risco cardiovascular; e quantificação do perfil lipídico, glicemia em jejum, pcr ultrassensível, dímero D, sCD14, sCD163, il-6 e il-18. A comparação foi feita por Anova ou teste de Kruskal-Wallis e a correlação pelo coeficiente de Spearman. Resultados. Embora não tenha havido diferenças significativas nos índices de Framingham, dad ou cimt, os indivíduos controladores apresentaram valores de triglicerídeos mais baixos, em comparação com os progressores. Não foram observadas diferenças em marcadores como pcr ultrassensível, il-6, il-18 e sCD163, entre os grupos estudados. O hdl médio foi maior em indivíduos progressores em terapia antiviral, e o cimt em indivíduos controladores foi negativamente correlacionado com o sCD14. Conclusão: os indivíduos controladores apresentam um perfil cardiovascular diferente dos indivíduos progressores, de acordo com os biomarcadores metabólicos e imunológicos avaliadosCOL001244418application/pdfengUniversidad del Rosario, Escuela de Medicina y Ciencias de la SaludBogotá, Colombiahttp://creativecommons.org/licenses/by-nc-nd/2.5/co/https://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Evaluation of Differences in Metabolic and Immunologic Markers and Cardiovascular Risk in hiv-1 PatientAvaliação da relação entre marcadores metabólicos, imunológicos e de risco cardiovascular em pacientes com hiv-1Evaluación de la relación entre marcadores metabólicos, inmunológicos y de riesgo cardiovascular en pacientes con vih-1Artículo de investigaciónhttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARThttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionVIH-1HIV-1Enfermedades CardiovascularesCardiovascular DiseasesInflamaciónInflammationProgresión de la EnfermedadDisease ProgressionRev. Cienc. Salud183119Revista Ciencias de la SaludPublicationCC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8823https://bibliotecadigital.udea.edu.co/bitstreams/33f6b4ee-1df8-486f-852c-e5dc5dfaa111/downloadb88b088d9957e670ce3b3fbe2eedbc13MD52falseAnonymousREADLICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstreams/87ca7470-369c-4b71-a14e-38d8c1c47683/download8a4605be74aa9ea9d79846c1fba20a33MD53falseAnonymousREADORIGINALCastroGustavo_2021_EvaluationDifferencesMetabolic.pdfCastroGustavo_2021_EvaluationDifferencesMetabolic.pdfArtículo de investigaciónapplication/pdf406938https://bibliotecadigital.udea.edu.co/bitstreams/4c1bd81b-9958-4a32-9f34-d04045a4f148/download0af4898dfceb641ef57e749dc6283727MD51trueAnonymousREADTEXTCastroGustavo_2021_EvaluationDifferencesMetabolic.pdf.txtCastroGustavo_2021_EvaluationDifferencesMetabolic.pdf.txtExtracted texttext/plain50664https://bibliotecadigital.udea.edu.co/bitstreams/b179c938-7bd4-4674-9163-0fe17aa2fae4/download0df81b111855b981a2a41418c226f03bMD54falseAnonymousREADTHUMBNAILCastroGustavo_2021_EvaluationDifferencesMetabolic.pdf.jpgCastroGustavo_2021_EvaluationDifferencesMetabolic.pdf.jpgGenerated Thumbnailimage/jpeg11414https://bibliotecadigital.udea.edu.co/bitstreams/b7a9a250-e2f8-4b8e-a5da-2a83841743bd/downloadf6de93ade7e3ed21999a7f9530e067fdMD55falseAnonymousREAD10495/36373oai:bibliotecadigital.udea.edu.co:10495/363732025-03-26 21:41:40.608http://creativecommons.org/licenses/by-nc-nd/2.5/co/open.accesshttps://bibliotecadigital.udea.edu.coRepositorio Institucional de la Universidad de Antioquiaaplicacionbibliotecadigitalbiblioteca@udea.edu.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